Demand oxygen delivery systems (DODS) enable prolongation of liquid oxygen cylinder life compared to continuous oxygen flow (CONT) use. Evidence is lacking, however, regarding their efficacy. This study investigated the literature comparing liquid-based CONT to DODS in patients with chronic obstructive pulmonary disease (COPD). Four electronic databases were searched from 1980 until January 2018. Primary outcomes were oxyhaemoglobin saturation (SpO 2 %) at rest and during exercise and exercise performance. Risk of bias was evaluated using the Cochrane tool. Data were analysed via meta-analysis where possible using the generic inverse variance method in Revman 5.3 or narrative synthesis. Ten crossover trials involving 152 patients with moderate to severe COPD (forced expiratory volume in 1 s (FEV 1 ) range: 27-42% predicted) were included. There was a large degree of uncertainty regarding potential bias related to allocation concealment and blinding for all studies. Data from three studies (n = 44) showed no significant differences between DODS and CONT in terms of SpO 2 % at rest −0.2% (95% CI: −0.5% to 0.1%) or during exercise −0.3% (95% CI: −2.1% to 1.5%). The pooled mean difference of two studies (n = 56) in 6-min walk distance was 5.7 m (95% CI: −14.4 to 25.8 m). Findings were consistent between the meta-analysis and narrative synthesis. These findings from a limited number of studies suggest oxygen delivery via DODS or CONT confers similar effects in terms of SpO 2 % or exercise performance in patients with COPD. However, as DODS devices use various specifications that may yield large intraindividual differences, individual SpO 2 % testing appears advisable for those considering DODS use.
INTRODUCTION
Long-term oxygen therapy (LTOT) for patients with chronic obstructive pulmonary disease (COPD) and chronic hypoxia is a crucial therapy that aims to improve survival. 1, 2 In these individuals, use of supplemental oxygen during exercise may also be associated with reduced exertional oxyhaemoglobin desaturation and increased exercise performance. 3 Oxygen therapy is usually applied via nasal cannula connected to stationary or portable continuous oxygen flow (CONT) systems, however significant oxygen wastage occurs due to unnecessary flow during expiration. This reduces the life of portable liquid-based oxygen devices which may subsequently impair mobility and independence. 4 Oxygen conservation devices therefore emerged (since the 1980s) with demand oxygen delivery system (DODS) being one of the most common technologies. DODS deliver a pre-set bolus of oxygen during the first part of inspiration, 5 triggered by a sensor that detects negative pressure within the nares. 6 No flow is provided during expiration. However, despite technological advancements and widespread commercial availability, evidence regarding the efficacy of DODS compared to CONT has been lacking. 7, 8 This is essential to clarify as concerns exist regarding the ability of DODS to meet respiratory demands in some situations. For example, dyssynchrony between triggering and inspiration may result in poorly timed gas delivery, while breathing pattern differences between the resting state and active exertion may limit the effectiveness of DODS during times of high peak inspiratory flow demand such as exercise.
Portable oxygen concentrators have also recently emerged as alternate delivery systems for patients requiring LTOT. These units deliver oxygen via extraction from ambient air rather than from a compressed liquid reservoir. While this mechanistic difference may offer benefits related to patient convenience and lower cylinder costs, it makes head-to-head comparisons between liquid-based and concentrator systems challenging. For example, it would be difficult to ascertain whether differences between portable oxygen concentrators and liquid cylinders + DODS should be attributed to oxygen type, bolus volumes or issues related to peak inspiratory flow rates.
To ensure that clinical decisions regarding oxygen delivery devices are informed by the best available evidence, it is essential to identify the quality and quantity of available literature and ascertain its applicability to clinical practice. This study therefore aimed to review the scientific literature comparing the effectiveness of liquid oxygen supplementation delivery via CONT or DODS at rest and during exercise in patients with COPD.
METHODS
This review and meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement 9 and was registered a priori at the international prospective register of systematic reviews (PROSPERO at www.crd. york.ac.uk under following ID: CRD42018081806).
Data sources and search strategy
The electronic databases PubMed (MEDLINE), Embase, LILACS and Cochrane Library were searched from 1980 until 5 January 2018 with a strategy comprising the following terms: chronic obstructive pulmonary disease OR COPD AND oxygen therapy OR demand oxygen system OR continuous flow system OR oxygen conserving device OR long-term oxygen therapy. Reference lists of included studies were hand-searched for additional literature.
Eligibility criteria
Full text, original research articles were included if they compared CONT supplemental oxygen delivery to DODS (both liquid-based) at rest and/or during exercise applied via nasal cannula. Articles must have been controlled trials published in English or German language involving patients with COPD (or COPD patient subgroup data available if mixed patient disease groups). Studies comparing CONT to air or oxygen concentrator systems were ineligible, as were book chapters, letters, unpublished work and study protocols.
Outcomes
To identify evidence of physiological benefit, this review focused on short-term physiological and functional outcomes. The primary review outcome was oxyhaemoglobin saturation (SpO 2 %) recorded at rest and during exercise, derived from arterial blood gas sampling or pulse oximetry. The secondary outcome was exercise performance, measured via field walking tests such as the 6-min walk test (6MWT) or shuttle walk test. As we anticipated that most studies would be of a 'laboratory' nature, we did not include broader outcomes such as quality of life (despite their clinical relevance).
Data extraction and risk of bias assessment
Two independent reviewers (R.G. and L.B.) screened potentially eligible citations on title and abstract and classified them as 'include', 'exclude' or 'maybe'. Those deemed 'include' or 'maybe' were reviewed in full text. The same two authors examined these studies to determine suitability for inclusion, with any disagreements resolved by a third author (C.O.). A standardized data collection form was used to extract information and outcomes related to included studies. This was conducted by one member of the review team (L.B.) and with confirmatory checks of accuracy verified by another team member (D.L.). This template included data for all review outcomes as well as study characteristics related to authors, country, year, baseline characteristics of study population, oxygen device used and CONT and DODS settings. The methodological quality of each included study was assessed using the Cochrane Collaboration's Risk of Bias tool. 10 Each included study was rated as low, high or unclear risk of bias by two independent reviewers for the domains of selection, performance, detection, attrition, reporting and other bias.
Data analysis
Data were pooled, where possible, for meta-analysis using RevMan 5.3 (The Cochrane Collaboration, Oxford, UK). As all included studies were crossover designs, we only meta-analysed data that could be entered via the generic inverse variance method, and expressed findings as mean differences (DODS − CONT). Data were not pooled where data were expressed in heterogeneous metrics (e.g. 6MWT vs 12-min walk test (12MWT)). Findings deemed unsuitable for meta-analysis were synthesized narratively and presented in summary tables. Statistical heterogeneity was explored between studies using the I 2 statistic, with results <25% considered low, 50-75% considered moderate and >75% considered high.
11 Data were primarily pooled using a fixed-effect model; however, a random-effects model was used where moderate (or greater) heterogeneity was detected. Possible explanations for observed heterogeneity were examined via exploratory sensitivity analyses involving removal of outlying studies. Data related to SpO 2 % at rest and during exercise were pooled separately from each other to avoid introducing issues of data duplicity. More Information on data analysis can be found in Appendix S1 (Supplementary Information).
RESULTS
An overview of the study selection process (PRISMA diagram) is provided in Figure 1 . A total of 726 titles were screened, resulting in the retrieval of 31 full-text articles for potential eligibility. Twenty-one studies were excluded due to use of an inappropriate comparator intervention (e.g. ambient air, oxymizer pendants and oxygen concentrators; n = 18) or non-COPD patients (n = 3). The remaining 10 publications [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] were included in the qualitative analysis (Table 1) . These studies comprised 152 patients with forced expiratory volume in 1 s (FEV 1 ) ranging from 27% to 42% predicted. Nine studies included patients with chronic hypoxia (partial pressure of oxygen in arterial blood (PaO 2 ): 49 to 60 mm Hg at rest on room air) and one study 15 included patients who desaturated more than 4% during a 6MWT (PaO 2 : 63 AE 9 mm Hg at rest on room air). One study 18 included patients with COPD and interstitial lung disease; however, COPD-specific data were available.
Risk of bias assessment
A summary of risk of bias judgments for included studies is presented in Figure 2 . High risks related to selection and performance bias were mostly confined to the outcome of exercise performance, as measures of oxygen saturation were deemed less likely to have been affected considering its physiological basis. Nonrandomized studies were deemed to be at high risk of selection and performance bias; however, the study of Tiep et al. 20 was rated unclear for performance bias as data were only available for oxygen saturation. Blinding of patients or therapists to knowledge of treatment condition, whether stated, was not possible for any study due to challenges concealing the audible noise and sensation during each oxygen bolus delivery for DODS. High ratings were only made for studies that included data related to exercise performance. A high degree of uncertainty was evident for many domains of the risk of bias tool, likely driven by the less stringent reporting standards required by the journals at the time of publication.
Primary outcome
Data regarding oxygen saturation at rest were available from six studies of 107 patients (Table 2) , 12, 13, 17, 18, 20, 21 with three studies 12, 18, 20 providing appropriate data for meta-analysis. The pooled mean difference (DODS − CONT) in oxygen saturation at rest was −0.2% (95% CI: −0.5% to 0.1%; Fig. 3A) . Findings from studies unable to be included in the meta-analysis for this outcome reported differences ranging between −1.3% and 2.0%. Data regarding oxygen saturation during exercise were available from eight studies of 123 patients (Table 2) , [12] [13] [14] [15] [18] [19] [20] [21] with three studies 12, 18, 20 providing appropriate data for meta-analysis. The pooled mean difference (DODS − CONT) in oxygen saturation during exercise was −0.3% (95% CI: −2.1% to 1.5%; Fig. 3B ). High statistical heterogeneity was detected (I 2 = 86%), hence a random-effect model was applied. This heterogeneity was attributable to the study data from Tiep et al.. 20 Sensitivity analysis involving removal of this study from analysis fully corrected this observation (I 2 = 0%). Findings from studies unable to be included in the meta-analysis for this outcome reported differences ranging between −3.0% and 1.0%.
Secondary outcome
Data regarding exercise performance were available from six studies of 107 patients (Table 3) , [13] [14] [15] 18, 19, 21 with two studies 18, 21 providing appropriate data for metaanalysis. The pooled mean difference (DODS − CONT) in exercise performance (6MWT distance) was 5.7 m (95% CI: −14.4 to 25.8 m; Fig. 3C ). High statistical heterogeneity was detected (I 2 = 89%), hence a randomeffect model was applied. As only two studies were included in this meta-analysis, sensitivity analysis was not indicated. Findings from studies unable to be included in the meta-analysis for this outcome reported highly comparable measures of exercise performance between groups (Table 3) , with the exception of the study by Braun et al. 13 This study evaluated exercise performance by the less common 12MWT but found consistently higher values for the CONT condition compared to three DODS devices. The difference ranged from −62 m for the Oxymatic device to −254 m for the Portamate device, however, these differences were not statistically significant. The available data suggest that use of DODS devices appear to confer minimal impact upon oxygen saturation and exercise performance compared to continuous flow oxygen. These findings were very consistent between the meta-analysis as well as the raw data presented in Tables 2 and 3 . This reassures us of their ability to prolong cylinder life without risking therapeutic effectiveness. The study by Tiep et al. 20 was the only notable exception to this result, which reported findings favouring CONT over DODS. This was one of the two non-randomized studies, with the CONT condition applied consistently prior to DODS. This raises the possibility of a test sequence effect. The small magnitude of mean difference (DODS − CONT) in oxygen saturation (2.5%) for this study, however, lies within the range of accepted measurement error for pulse oximetry. The clinical relevance of this finding is therefore questionable. 22 The only other study to report a significant difference between systems was that of Weber et al., 21 where a mean difference of 16 m on 6MWT favouring DODS, although this was less than the 30 m threshold of a minimal important difference. 23 Despite good congruency between DODS and CONT findings across most studies, the degree of individual patient variability within studies was notably high. For example, DODS use was observed to be associated with oxygen desaturations in excess of 20% during exercise in one study 15 but substantially less during CONT use. Tiep et al. 20 observed inferior results with DODS during exercise in 60% of participants, but noted partial diminishment when oxygen delivery settings were increased. Variability to such an extent suggests that the effect of DODS devices cannot be accurately estimated at the level of the individual. Factors such as mouth breathing, especially during exercise, may play an important role in identifying subgroups with greater need for individual evaluation prior to DODS implementation due to the risk of ineffectively triggering oxygen boluses.
An important factor to consider with respect to evaluating DODS suitability is the ever-increasing array of device manufacturers, features and specifications. For example, bolus volume can vary from 15 to 100 mL and bolus duration from 50 to 900 ms. Earlier timing of oxygen delivery within the inspiration phase has been shown to associate with better oxygenation. 24 Studies included in this meta-analysis used different devices and, in several cases, indeterminable DODS setting. Two studies used a device that releases an oxygen bolus during every second inspiration phase 16, 19 , two studies increased DODS level to achieve an oxygen saturation above 90% 18, 20 , while all other studies used unspecified equations to calculate DODS oxygen flow rates considered to be (at least theoretically) equivalent to the comparator of 2-3 L/min CONT. This implies they are not comparable from one manufacturer or model to another. It would therefore seem advisable to consider that DODS device prescription for LTOT be undertaken in conjunction with oxygen saturation monitoring during measures of exercise or activities of daily living while using the device under consideration. 6 A principal function of DODS devices is prolongation of cylinder life. Economic benefits may therefore be conferred due to reductions in total oxygen consumption and home deliveries. Estimates of cost savings have ranged from 11% to 55% when DODS devices were compared to CONT, 12, [25] [26] [27] reiterating not all DODS devices are equal. Patients with COPD are also highly impaired in their daily physical activities. Those with severe COPD but no LTOT report 50% lower physical activity levels compared to healthy elderly people. 28 LTOT is an independent determinant for physical inactivity 29 and those with COPD who use LTOT are even more inactive (79% lower), despite similar lung function impairment. 28 Many COPD patients report difficulties carrying portable continuous flow oxygen systems due to heavy cylinder weight. 30 The reduced bulk and weight offered by DODS in conjunction with smaller (but longer lasting) cylinders is a preferable option 18 that may contribute to improvements in physical activity levels. The potential translation of such adaptations into daily life is an important and plausible mechanism that may be further enhanced via emerging lightweight portable concentrators. No such studies have, however, been conducted for this purpose.
It is important to note that all studies included within this review were conducted in a laboratory setting. This controlled environment enables accurate evaluation of physiological parameters essential for the primary aim of such studies, however does not mimic community-based daily life. Additionally, no included study evaluated patient-reported outcomes such as quality of life. This significantly understates the importance of such outcomes to clinical decision-makers. Future reviews seeking to determine the multidimensional impact of LTOT on daily life (beyond the scope of the present review) would require altered methodology such as the inclusion of studies that did not need to involve direct head-to-head comparisons between CONT and DOD.
The effect of nocturnal DODS use has also seldom been explored, with very few studies of small sample sizes investigating DODS during sleep. 12, 31 One study found no clinical difference in oxygen saturation compared to CONT; however, dramatic oxygen desaturation (up to 11 percentage points) was observed in some subjects using DODS attributed to ineffective triggering. 31 No sound evidence-based recommendations can presently be made to inform decisions regarding the effectiveness of DODS devices at night.
Despite robust methodology, this review resulted in a synthesis of data from 10 studies of 152 patients with COPD, with only 107 patients included in the metaanalysis for SpO 2 at rest. This pooled sample size appears modest, but must be considered with respect to the inherent trial designs of the included studies. All included studies were crossover trials, which is appropriate to investigate the research questions addressed in this review. The advantages afforded by participants acting as their own controls (e.g. reduced outcome variability and greater statistical power) reflect, however, as a lower pooled yield. The review findings may also need to be interpreted with caution due to the uncertain relevance of some included studies dating as far back as 1988. To the best of the authors' knowledge, only 7 of 17 (41%) DODS devices included in this review are currently commercially available. The modern clinical environment is increasingly observing a rise of portable oxygen concentrators. As these devices have different mechanistic capabilities to liquid-based CONT and DODS devices, and were not considered within the scope of the present review, we do not promote extrapolation of findings to such devices. Finally, while patients with COPD represent the largest patient population using LTOT, extrapolation of findings to other chronic respiratory conditions may be fraught with risk due to known differences in respiratory pathophysiology.
In conclusion, DODS devices appear to offer similar effects to CONT systems in maintaining oxygen saturation at rest and during exercise, with similar effects upon exercise performance. The limited amount of high-quality data and large degree of individual variability, however, means overall effects may not be accurately estimated at the individual level. Decisions regarding DODS use for LTOT should be made in conjunction with oxygen saturation monitoring during measures of exercise or activities of daily living for specific devices under consideration. Further research is indicated to address the significant gap in the literature identified via this review in order to facilitate evidencebased medicine in this area.
Abbreviations: , 6MWT, 6-min walk test; 12MWT, 12-min walk test; CONT, continuous oxygen flow; DODS, demand oxygen delivery system; FEV 1 , forced expiratory volume in 1 s; LTOT, long-term oxygen therapy; PaO 2 , partial pressure of oxygen in arterial blood; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; SpO 2 , oxyhaemoglobin saturation.
